Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

295
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
295
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

165
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
165
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

499
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
499
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

997
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
997
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

526
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
526
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

141
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone and Radiologic Findings in Congenital Generalized Lipodystrophy: A Systematic Review and Report of 60 Cases.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

Type B insulin resistance with glycemic extremes: a case report and literature review.

Frontiers in endocrinology·2026
Same author

Case Report: Twenty years of metreleptin therapy in congenital generalized lipodystrophy type 1: the longest reported follow-up to date.

Frontiers in endocrinology·2026
Same author

Classical homeostatic physiology sheds light on vitamin D controversies.

Trends in endocrinology and metabolism: TEM·2026
Same author

Genetics of Response to Canagliflozin (GRC) Study: Rationale, Design, and Pharmacodynamic Responses.

Clinical and translational science·2026
Same author

Genotype-first approach reveals monogenic lipodystrophy is underdiagnosed, with health and mortality risks.

EBioMedicine·2026
Same journal

From Chaos to Care: Personalized AI for Early Cardiac Arrhythmia Warning.

medRxiv : the preprint server for health sciences·2026
Same journal

Large distant deletion disrupts CDKN2A enhancer and predisposes to melanoma.

medRxiv : the preprint server for health sciences·2026
Same journal

Artificial Intelligence-Based Chatbots in Genetic Counseling Practice: Current Uptake, Utilization, and Perspectives.

medRxiv : the preprint server for health sciences·2026
Same journal

Longitudinal MAP-MRI-based Assessment of Tissue Microstructural Alterations in Acute mTBI.

medRxiv : the preprint server for health sciences·2026
Same journal

A class of deep intronic <i>IGHMBP2</i> variants activate a shared cryptic splice donor, enabling correction of select variants with a single antisense oligonucleotide.

medRxiv : the preprint server for health sciences·2026
Same journal

Global Socioeconomic Context and Brain Ageing in Epilepsy: an ENIGMA-Epilepsy study.

medRxiv : the preprint server for health sciences·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2025

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
08:44

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

4.2K

Tirzepatide for Lipodystrophy.

Rasimcan Meral, Merve Celik Guler, Diarratou Kaba

    Medrxiv : the Preprint Server for Health Sciences
    |January 13, 2025
    PubMed
    Summary
    This summary is machine-generated.

    Tirzepatide shows promise for treating lipodystrophy, a rare metabolic disorder. This dual incretin medication significantly improved BMI, HbA1c, and triglyceride levels in patients with partial or generalized lipodystrophy.

    More Related Videos

    Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
    08:30

    Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

    Published on: June 2, 2015

    9.3K
    Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
    07:59

    Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

    Published on: July 21, 2017

    9.6K

    Related Experiment Videos

    Last Updated: Jun 3, 2025

    Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
    08:44

    Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

    Published on: July 30, 2020

    4.2K
    Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots
    08:30

    Encapsulation Thermogenic Preadipocytes for Transplantation into Adipose Tissue Depots

    Published on: June 2, 2015

    9.3K
    Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
    07:59

    Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

    Published on: July 21, 2017

    9.6K

    Area of Science:

    • Endocrinology and Metabolism
    • Rare Genetic Disorders
    • Pharmacological Interventions

    Background:

    • Lipodystrophy is a group of rare disorders characterized by abnormal fat distribution and severe metabolic complications.
    • Reduced adipocyte mass in lipodystrophy leads to ectopic lipid storage and metabolic dysfunction.
    • Previous studies indicated benefits of glucagon-like peptide-1 agonists in familial partial lipodystrophy (FPLD).

    Purpose of the Study:

    • To investigate the efficacy of tirzepatide, a dual incretin, as a potential treatment for patients diagnosed with lipodystrophy.
    • To evaluate the impact of tirzepatide on metabolic parameters in individuals with partial lipodystrophy (PL) or generalized lipodystrophy (GL).

    Main Methods:

    • An observational cohort study tracked patients with PL or GL who were clinically treated with tirzepatide.
    • Data were collected within the framework of ongoing natural history studies of lipodystrophy.
    • Seventeen patients (14 with FPLD, 3 with acquired GL) received tirzepatide, with metabolic markers monitored over time.

    Main Results:

    • Tirzepatide treatment led to significant reductions in BMI, HbA1c, triglyceride levels, and daily insulin requirements in FPLD patients.
    • Patients with acquired generalized lipodystrophy (GL) also exhibited substantial improvements in BMI, HbA1c, triglycerides, and insulin needs.
    • Three patients experienced dose-limiting gastroesophageal reflux, hindering further dose escalation.

    Conclusions:

    • Tirzepatide demonstrates potential as an effective therapeutic agent for managing metabolic disturbances in patients with lipodystrophy.
    • The findings support further investigation into tirzepatide for lipodystrophy treatment, despite some tolerability issues.